Metformin and breast cancer: an opportunity for pharmacogenetics

Aging (Albany NY). 2022 Jul 18;14(14):5612-5613. doi: 10.18632/aging.204180. Epub 2022 Jul 18.
No abstract available

Keywords: HER2; breast cancer; metformin; single-nucleotide variant; type 2 diabetes.

Publication types

  • Editorial

MeSH terms

  • Breast Neoplasms* / drug therapy
  • Breast Neoplasms* / genetics
  • Diabetes Mellitus, Type 2*
  • Female
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Metformin* / pharmacology
  • Metformin* / therapeutic use
  • Pharmacogenetics
  • Receptor, ErbB-2

Substances

  • Hypoglycemic Agents
  • Metformin
  • Receptor, ErbB-2